A citation-based method for searching scientific literature

M Strupp, R Kalla, M Dichgans, T Freilinger, S Glasauer, T Brandt. Neurology 2004
Times Cited: 145



M Strupp, R Kalla, J Claassen, C Adrion, U Mansmann, T Klopstock, T Freilinger, H Neugebauer, R Spiegel, M Dichgans, F Lehmann-Horn, K Jurkat-Rott, T Brandt, J C Jen, K Jahn. Neurology 2011
Times Cited: 111




List of shared articles



Times cited



Vertigo Related to Central Nervous System Disorders.
Kamala Saha. Continuum (Minneap Minn) 2021
0

Fampridine and Acetazolamide in EA2 and Related Familial EA: A Prospective Randomized Placebo-Controlled Trial.
Carolin Muth, Julian Teufel, Ludger Schöls, Matthis Synofzik, Christiana Franke, Dagmar Timmann, Ulrich Mansmann, Michael Strupp. Neurol Clin Pract 2021
1

The neurological update: therapies for cerebellar ataxias in 2020.
J Gandini, Mario Manto, T Bremova-Ertl, K Feil, M Strupp. J Neurol 2020
10

Episodic Ataxias: Faux or Real?
Paola Giunti, Elide Mantuano, Marina Frontali. Int J Mol Sci 2020
1

A novel pathogenic CACNA1A variant causing episodic ataxia type 2 (EA2) spectrum phenotype in four family members and a novel combined therapy.
Josef Penkava, S Ledderose, S Chahrokh-Zadeh, A Munzig, Zu Eulenburg, D Huppert, M Strupp, S Becker-Bense. J Neurol 2020
0

Aminopiridines in the treatment of multiple sclerosis and other neurological disorders.
Laura De Giglio, Francesca Cortese, Elena Maria Pennisi. Neurodegener Dis Manag 2020
1

Aminopyridines and Acetyl-DL-leucine: New Therapies in Cerebellar Disorders.
Roger Kalla, Michael Strupp. Curr Neuropharmacol 2019
15

What Is Behind Cerebellar Vertigo and Dizziness?
Katharina Feil, Ralf Strobl, Alexander Schindler, Siegbert Krafczyk, Nicolina Goldschagg, Claudia Frenzel, Miriam Glaser, Florian Schöberl, Andreas Zwergal, Michael Strupp. Cerebellum 2019
14

Advances in pharmacotherapy of vestibular and ocular motor disorders.
Andreas Zwergal, Michael Strupp, Thomas Brandt. Expert Opin Pharmacother 2019
3

Impact of 4-aminopyridine on vestibulo-ocular reflex performance.
Marliawaty I Gusti Bagus, Clayton Gordy, Rosario Sanchez-Gonzalez, Michael Strupp, Hans Straka. J Neurol 2019
1

Recent Advances in the Treatment of Cerebellar Disorders.
Hiroshi Mitoma, Mario Manto, Jordi Gandini. Brain Sci 2019
3

Episodic ataxias.
Joanna C Jen, Jijun Wan. Handb Clin Neurol 2018
4

Episodic ataxias.
Joanna C Jen, Jijun Wan. Handb Clin Neurol 2018
21

Aminopyridines for the treatment of neurologic disorders.
Michael Strupp, Julian Teufel, Andreas Zwergal, Roman Schniepp, Kamran Khodakhah, Katharina Feil. Neurol Clin Pract 2017
29

Update on the Pharmacotherapy of Cerebellar Ataxia and Nystagmus.
Katharina Feil, Tatiana Bremova, Carolin Muth, Roman Schniepp, Julian Teufel, Michael Strupp. Cerebellum 2016
15

Mutations in the sodium channel gene SCN2A cause neonatal epilepsy with late-onset episodic ataxia.
N Schwarz, A Hahn, T Bast, S Müller, H Löffler, S Maljevic, E Gaily, I Prehl, S Biskup, T Joensuu,[...]. J Neurol 2016
51

Update on the pharmacotherapy of cerebellar and central vestibular disorders.
Roger Kalla, Julian Teufel, Katharina Feil, Caroline Muth, Michael Strupp. J Neurol 2016
13

The physiological basis of therapies for cerebellar ataxias.
Hiroshi Mitoma, Mario Manto. Ther Adv Neurol Disord 2016
22

[Diagnosis and current therapy of vestibular syndromes].
Michael Strupp, Thomas Brandt. Dtsch Med Wochenschr 2016
1

Treatable causes of cerebellar ataxia.
Adolfo Ramirez-Zamora, Warren Zeigler, Neeja Desai, José Biller. Mov Disord 2015
19

Pharmacotherapy of vestibular and cerebellar disorders and downbeat nystagmus: translational and back-translational research.
Michael Strupp, Andreas Zwergal, Katharina Feil, Tatiana Bremova, Thomas Brandt. Ann N Y Acad Sci 2015
22

[Pharmacotherapy of Vestibular Disorders, Nystagmus and Cerebellar Disorders].
K Feil, N Böttcher, O Kremmyda, C Muth, J Teufel, A Zwergal, T Brandt, M Strupp. Fortschr Neurol Psychiatr 2015
2

[Diagnosis and treatment options in vertigo syndromes].
M Strupp, M Dieterich, A Zwergal, T Brandt. Nervenarzt 2015
10

[Peripheral, central and functional vertigo syndromes].
M Strupp, M Dieterich, A Zwergal, T Brandt. Nervenarzt 2015
4

Consensus paper: management of degenerative cerebellar disorders.
W Ilg, A J Bastian, S Boesch, R G Burciu, P Celnik, J Claaßen, K Feil, R Kalla, I Miyai, W Nachbauer,[...]. Cerebellum 2014
88

Episodic ataxia type 2: phenotype characteristics of a novel CACNA1A mutation and review of the literature.
Wolfgang Nachbauer, Michael Nocker, Elfriede Karner, Iva Stankovic, Iris Unterberger, Andreas Eigentler, Rainer Schneider, Werner Poewe, Margarete Delazer, Sylvia Boesch. J Neurol 2014
33

Therapies for ataxias.
Laurence Martineau, Anne Noreau, Nicolas Dupré. Curr Treat Options Neurol 2014
1

The genetics of ataxia: through the labyrinth of the Minotaur, looking for Ariadne's thread.
M Mancuso, D Orsucci, G Siciliano, U Bonuccelli. J Neurol 2014
18

The mixed blessing of treating symptoms in acute vestibular failure--evidence from a 4-aminopyridine experiment.
Roswitha Beck, Lisa Günther, Guoming Xiong, Heidrun Potschka, Guido Böning, Peter Bartenstein, Thomas Brandt, Klaus Jahn, Marianne Dieterich, Michael Strupp,[...]. Exp Neurol 2014
17

The Clinical Spectrum of Autosomal-Dominant Episodic Ataxias.
Stefan Kipfer, Michael Strupp. Mov Disord Clin Pract 2014
10


A randomised double-blind, cross-over trial of 4-aminopyridine for downbeat nystagmus--effects on slowphase eye velocity, postural stability, locomotion and symptoms.
Jens Claassen, Rainer Spiegel, Roger Kalla, Mary Faldon, Christopher Kennard, Chotipat Danchaivijitr, Stanislaw Bardins, Nicole Rettinger, Erich Schneider, Thomas Brandt,[...]. J Neurol Neurosurg Psychiatry 2013
49

Does 4-aminopyridine "beat" downbeat nystagmus?
Aasef G Shaikh. J Neurol Neurosurg Psychiatry 2013
4

Pharmacotherapy of vestibular disorders and nystagmus.
Michael Strupp, Olympia Kremmyda, Thomas Brandt. Semin Neurol 2013
17

Neuronal P/Q-type calcium channel dysfunction in inherited disorders of the CNS.
Sanjeev Rajakulendran, Diego Kaski, Michael G Hanna. Nat Rev Neurol 2012
86


The use of aminopyridines in neurological disorders.
Saam Sedehizadeh, Michael Keogh, Paul Maddison. Clin Neuropharmacol 2012
23

Large Genomic Deletions in CACNA1A Cause Episodic Ataxia Type 2.
Jijun Wan, Hafsa Mamsa, Janine L Johnston, Elizabeth L Spriggs, Harvey S Singer, David S Zee, Alhamza R Al-Bayati, Robert W Baloh, Joanna C Jen. Front Neurol 2011
27

The role of regularity and synchrony of cerebellar Purkinje cells for pathological nystagmus.
Stefan Glasauer, Christian Rössert, Michael Strupp. Ann N Y Acad Sci 2011
10